Nadir prostate specific antigen (PSA) levels and time to nadir PSA (TnPSA) following radiotherapy have been proposed as predictors of outcome in prostate cancer. Ray et al. attempted to determine ...

Patients, who were assessed monthly to check their hematological parameters and prostate-specific antigen (PSA) levels, also underwent imaging investigations every 3–4 months. In total ...

Serum PSA levels are used to predict the prognosis of patients with prostate cancer, but assessment of the prognostic accuracy of PSA values is difficult, particularly in populations in which ...

The percentage of participants with detected cancer with stratification according to PSA level is shown in Table S5. Overall, 97 participants had a lesion with a PI-RADS score of 3 or higher and ...

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...